跳至主要内容
临床试验/NCT00796627
NCT00796627终止不适用

HIF-1 Regulated Circulating Angiogenic Cell Recruitment in Burn Wound Healing

Johns Hopkins University1 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2006年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
41
试验地点
1
主要终点
The Quantification of Circulating Angiogenic Cells in the Blood of Individuals Who Are Healthy Volunteers Compared to Those in Individuals Who Have Sustained a Burn Injury

研究概览

简要总结

This research is being done to increase knowledge about wound healing and different factors that may affect healing in burn patients.

详细描述

Burn injuries represent a major public health problem, requiring medical attention for more than one million Americans annually. Despite therapeutic advances, non-healing burn wounds and excessive scarring still result in significant long term physical and psychosocial morbidity. In this study we propose to perform clinical and research to study the role of circulating angiogenic cells (CAC) in promoting burn wound healing.

CAC's have been shown to contribute to vascularization and tissue repair in a number of animal models of tissue injury ischemia and mobilization of CACs into the peripheral blood has been demonstrated in burn wound patients.

We hypothesize that primary healing of burn wounds is dependent on repair of damaged vasculature, and that bone marrow derived stem cells, circulating angiogenic cells (CAC), play a critical role in the healing process. Furthermore we propose that the transcription factor Hypoxia Inducible Factor 1 alpha (HIF 1 alpha) through production of peptide products of its downstream target genes directs the "homing" of CAC's to the wound where they participate in healing events. The first aim of this study is to correlate mobilization of CAC's into the blood stream with the success of burn wound healing.

CAC's have been shown to contribute to vascularization and tissue repair in a number of studies. The relationship between mobilization of CAC's and burn wound healing has not been examined. In addition to surveying CAC numbers in the peripheral blood, we will assay levels of the putative mediators of CAC mobilization: Vascular Endothelial Growth Factor (VEGF), Placenta Growth Factor (PLGF), and Stromal Cell-Derived Factor (SDF-1). We hypothesize that individuals who are able to mount a large and sustained mobilization of CAC's into the peripheral blood from the bone marrow, will be more likely to heal the injured vasculature and go on to primary healing. Individuals with an inadequate mobilization of CAC's will fail to repair the damaged vasculature in the wound and proceed to necrosis and "conversion" to third degree, necrotic burn wounds.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

盲法说明

Open Label

入排标准

年龄范围
14 Years 至 75 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Recruitment of patients at the Johns Hopkins Regional Burn Center for study will be based upon the following clinical criteria:
  • •Second degree scald burn of 10 cm2
  • •Age between 14 to 75 years
  • •Burn area equal or less than 95% of Burn Surface Area (BSA)
  • •Body temperature between 98.5 and 101 degree F
  • •Informed consent for enrolment into study
  • •Spanish speaking patients will be included when we have a Spanish consent form available.

排除标准

  • •First and third degree burn wounds
  • •Hemodynamic instability (SBP below 100, Heart Rate (HR) over 100, urine output less than 30 ml/hour
  • •Area of burn over 20% of BSA
  • •Hypothermia T<98.5 or Hyperthermia T>101 degree F
  • •Urine output less than 30 ml/hour
  • •Serum albumin less than 3 mg/ml.
  • •Subjects weighing less than 50 kg.

研究组 & 干预措施

Healthy volunteers

Sham Comparator

Healthy volunteers with no burn wounds Volunteers donate blood that will be studied in comparison to patients who have sustained burns. The circulating "bone marrow stem cells" will be counted and compared to the levels in burn patients. Six 12 ml tubes will be taken for the study. You will not be compensated. But you will be helping to advance science if you join the study.

干预措施: Healthy volunteers (Genetic)

Burn volunteer

Active Comparator

To recruit burn wound patients with defined clinical criteria for study. A second-degree burn of at least 10 cm2 to up to 95% BSA; age = 14-75 years; BP > 100 mm Hg systolic; heart rate < 100 beats/minute; urine output > 30 ml/hour; area of burn < 20% of BSA; body temperature = 98.5-101 degrees Fahrenheit; serum albumin > 3 mg/ml; and informed consent. We will also obtain a history regarding the presence or absence of risk factors that may affect CAC numbers: hypertension > 1 year; smoking > 2 pack-years or within the last year; diabetes mellitus; and family history of premature coronary artery disease (men < 55 and women < 65 years of age).Six 12 ml tubes will be taken at 5 time points

干预措施: Burn volunteers (Other)

结局指标

主要结局

The Quantification of Circulating Angiogenic Cells in the Blood of Individuals Who Are Healthy Volunteers Compared to Those in Individuals Who Have Sustained a Burn Injury

时间窗: baseline

Tissue samples were harvested from healthy volunteers and participants who sustained burns. CACs were isolated and counted under fluorescence microscopy.

Mean of Circulating Angiogenic Cells in the Blood of Individuals Who Have Sustained a Burn Injury

时间窗: 73 hours to 6 weeks post-operative

Tissue samples were harvested from healthy volunteers and participants who sustained burns. CACs were isolated and counted under fluorescence microscopy.

Mean of Circulating Angiogenic Cells in the Blood of Individuals Who Have Sustained a Burn Injury

时间窗: 0 to 24 hours post-operative

Tissue samples were harvested from healthy volunteers and participants who sustained burns. CACs were isolated and counted under fluorescence microscopy.

Mean of Circulating Angiogenic Cells in the Blood of Individuals Who Have Sustained a Burn Injury

时间窗: 49 to 72 hours post-operative

Tissue samples were harvested from healthy volunteers and participants who sustained burns. CACs were isolated and counted under fluorescence microscopy.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Hypoxia-inducible Factor-1 (HIF-1) Regulated... | 临床试验